DINA GIBSON: Open Payments
NPI 1063998912 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 37 payments from 13 companies in 2025. Trend: 2023 $493 · 2024 $1,047 · 2025 $1,775
Food & beverage: $1,690Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $586 |
| Mallinckrodt Hospital Products Inc. | 2 | $225 |
| Gilead Sciences, Inc. | 6 | $209 |
| ABBVIE INC. | 5 | $184 |
| Madrigal Pharmaceuticals | 1 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $114 |
| Merit Medical Systems Inc | 1 | $104 |
| GENZYME CORPORATION | 2 | $80 |
| Lilly USA, LLC | 1 | $58 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
Products named: TREMFYA, TERLIVAZ, SKYRIZI, REZDIFFRA, DUPIXENT, ESOPHYX, ENTYVIO, ZEPBOUND.
Industry payments across AZ — which companies pay providers there.
